Glaxo Turns its Eye to ‘Bubble Boy Disease’ in Rare Disease Push


Published On: October 19th, 2010

Glaxo has licensed an experimental gene therapy from two Italian institutions that aims to fix the stem cells in the patient’s own bone marrow.

Original post: 
Glaxo Turns its Eye to ‘Bubble Boy Disease’ in Rare Disease Push



Loading...


Comments are closed.